Glycaemic memory

British Journal of Diabetes and Vascular Disease

Volumn 8, Issue 5, 2008, Pages 242-247

  Bailey, Clifford J ^a   Day, Caroline ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Glycaemic control; Glycaemic memory; Hyperglycaemic memory; Intensive

Indexed keywords

HEMOGLOBIN A1C; METFORMIN;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; EARLY INTERVENTION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MICROALBUMINURIA; MOLECULAR MECHANICS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; RETINA MACULA EDEMA; RISK FACTOR; VASCULAR DISEASE;

EID: 58049096545     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651408098784     Document Type: Article

References (19)

1. The Diabetes Control and Complications Trial research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.
2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study research group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-53.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-53.
4. Holman RR, Paul SK, Bethel MA et al. 10-Year follow-up of intensive glucose control in type 2 Diabetes. UKPDS 80. N Engl J Med 2008; 10 Sep
5. Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2006; 49:1711-21.
6. Duckworth W. Veterans Affairs Diabetes Trial. 68th American Diabetes Association, Annual Conference, 6-10 June 2008, San Francisco, USA. {1}
7. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348:383-93.
8. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358:580-91.
9. UKPDS Group. UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990; 13:1 -11.
10. Diabetes UK Audit Project. Audit shows 10-year delay in diagnosing type 2 diabetes. Diabetes Update 2000; Winter:1.
11. Haffner SJ, Cassells H. Hyperglcemia as a cardiovascular risk factor. Am J Med 2003; 115(8A):6S-11S.
12. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003; 26:688-96.
13. Khaw KT, Wareham N, Bingham S et al. Association of haemoglobin A1c with cardiovascular disease and mortality in adults: the European Prospective Investigation Into Cancer in Norfolk. Ann Intem Med 2004; 141:413-20.
14. Ceriello A, Esposito K, Piconi L et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57: 1349-54.
15. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-59.
16. Kosiborod M, Inzucchi S, Krumholz HM et al. Glucometrics in patients hospitalized with acute myocardial infarction. Circulation 2008; 117:1018-27.
17. The Advance collaborative group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-72.
18. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414:813-20.
19. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis. JAMA 2002; 287:2570-81.